Abstract
A set of one hundred and twenty two coumarin derivatives with TNF-α inhibitory activity was subjected to the two dimensional quantitative structure activity relationships (2D-QSAR) studies using MDS 3.0 drug designing module with Multiple Linear Regression (MLR), Principle Component Regression (PCR) and Partial Least Square Regression (PLS) analysis being carried out. Among these three methods, PCR-model has come out with significant result as compared to other models. The best PCR QSAR model (r2 = 0.8721, Fisher test value F = 40.67, Pred_r2 = 0.654) has acceptable statistical quality and predictive potential as indicated by the value of cross validated squared correlation coefficient (q2= 0.7123). From the build model it seems to be clear that SaaCHE-index, T_2_O_1, T_N_O_6 contributes positively while as SssCH2E-index descriptor negatively contributes to the biological activity. Thus this validated model brings important structural insight to aid the design of novel coumarins TNF- α inhibitor as anti-cancer agents.
Keywords: Coumarins, Cancer, TNF-α, Multiple Linear Regression (MLR), Principle Component Regression (PCR), Partial Least Square Regression (PLSR), QSAR, 1H NMR, Mass spectroscopical data, cancer, molecular anatomy, benzothiazole, aryl hydrocarbon receptor (AhR), melanoma, leismaniacidal, orthophosphoric acid
Letters in Drug Design & Discovery
Title: A QSAR Analysis of Coumarin Derivatives as TNF-α Inhibitor - A Rational Approach to Anticancer Drug Design
Volume: 8 Issue: 9
Author(s): Malleshappa N. Noolvi, Harun M. Patel and Tarandeep Kaur
Affiliation:
Keywords: Coumarins, Cancer, TNF-α, Multiple Linear Regression (MLR), Principle Component Regression (PCR), Partial Least Square Regression (PLSR), QSAR, 1H NMR, Mass spectroscopical data, cancer, molecular anatomy, benzothiazole, aryl hydrocarbon receptor (AhR), melanoma, leismaniacidal, orthophosphoric acid
Abstract: A set of one hundred and twenty two coumarin derivatives with TNF-α inhibitory activity was subjected to the two dimensional quantitative structure activity relationships (2D-QSAR) studies using MDS 3.0 drug designing module with Multiple Linear Regression (MLR), Principle Component Regression (PCR) and Partial Least Square Regression (PLS) analysis being carried out. Among these three methods, PCR-model has come out with significant result as compared to other models. The best PCR QSAR model (r2 = 0.8721, Fisher test value F = 40.67, Pred_r2 = 0.654) has acceptable statistical quality and predictive potential as indicated by the value of cross validated squared correlation coefficient (q2= 0.7123). From the build model it seems to be clear that SaaCHE-index, T_2_O_1, T_N_O_6 contributes positively while as SssCH2E-index descriptor negatively contributes to the biological activity. Thus this validated model brings important structural insight to aid the design of novel coumarins TNF- α inhibitor as anti-cancer agents.
Export Options
About this article
Cite this article as:
N. Noolvi Malleshappa, M. Patel Harun and Kaur Tarandeep, A QSAR Analysis of Coumarin Derivatives as TNF-α Inhibitor - A Rational Approach to Anticancer Drug Design, Letters in Drug Design & Discovery 2011; 8 (9) . https://dx.doi.org/10.2174/157018011797200768
DOI https://dx.doi.org/10.2174/157018011797200768 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Collagen: The Oldest Scaffold for Tissue Regeneration
Current Tissue Engineering (Discontinued) Quantitative Imaging Biomarkers and their Emerging Role
Current Medical Imaging Interaction Between Bone and Muscle in Older Persons with Mobility Limitations
Current Pharmaceutical Design The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Current Cancer Drug Targets New N,N,N’,N’-tetradentate Pyrazoly Agents: Synthesis and Evaluation of their Antifungal and Antibacterial Activities
Medicinal Chemistry Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-based Diet
Current Pharmaceutical Design Structure-Activity Relationship Analyses of Glycyrrhetinic Acid Derivatives as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Preparation and Cytotoxic Activities of Fatty Acid Derivatives of 20(S)- Protopanaxatriol
Letters in Drug Design & Discovery Recent Advances in Protein and Peptide Drug Delivery: A Special Emphasis on Polymeric Nanoparticles
Protein & Peptide Letters Omega-3 Fatty Acids: Role in the Prevention and Treatment of Psychiatric Disorders
Current Psychiatry Reviews Self-Assembly of DNA and Cell-Adhesive Proteins onto pH-Sensitive Inorganic Crystals for Precise and Efficient Transgene Delivery
Current Pharmaceutical Design Treating Age-Related Macular Degeneration – Interaction of VEGF-Antagonists with their Target
Mini-Reviews in Medicinal Chemistry Challenges and Solutions in Proteomics
Current Genomics Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers
Current Medicinal Chemistry Polo-Like Kinase 1 as a Potential Therapeutic Target for Osteosarcoma
Current Pharmaceutical Design Assessment of Retinal Structural and Functional Characteristics in Eyes with Autoimmune Retinopathy
Current Molecular Medicine Pattern of Care for Skin Cancers - Canada and France
Current Cancer Therapy Reviews Soy Isoflavones and Cardiovascular Health: An Update
Current Nutrition & Food Science Hypoxic Culture Conditions for Mesenchymal Stromal/Stem Cells from Wharton’s Jelly: A Critical Parameter to Consider in a Therapeutic Context
Current Stem Cell Research & Therapy Macrocyclic Lactones and Cellular Transport-Related Drug Interactions: A Perspective from In Vitro Assays to Nematode Control in the Field
Current Pharmaceutical Biotechnology